ALQGC — Quantum Genomics SA Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Quantum Genomics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | FAS | FAS | FAS | FAS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | -9.08 | -11.5 | -16.6 | -24.9 | — |
Depreciation | |||||
Non-Cash Items | -0.211 | 0.001 | 0 | 0.451 | — |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.38 | -0.592 | -0.59 | 9.51 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -10.7 | -12 | -16.9 | -15 | — |
Capital Expenditures | -0.018 | -0.411 | -0.045 | -0.033 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.005 | -0.17 | 0.018 | -0.12 | — |
Change in Net Investments | |||||
Change in Net Intangibles | |||||
Cash from Investing Activities | -0.013 | -0.581 | -0.028 | -0.153 | — |
Financing Cash Flow Items | -0.337 | -0.001 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 7.04 | 28.5 | 3.29 | 17.2 | — |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -3.63 | 16 | -13.6 | 2.09 | — |